Pubblicazioni

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial

2017 - HAEMATOLOGICA

Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, SÃ©bastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, FrÃ©dÃ©ric

STAT1 activation in association with JAK2 exon 12 mutations

2016 - HAEMATOLOGICA

Godfrey, Anna L.; Chen, Edwin; Massie, Charles E.; Silber, Yvonne; Pagano, Francesca; Bellosillo, Beatriz; Guglielmelli, Paola; Harrison, Claire N.; Reilly, John T.; Stegelmann, Frank; Bijou, Fontanet; Lippert, Eric; Boiron, Jean-Michel; DÃ£Â¶hner, Konstanze; Vannucchi, Alessandro M.; Besses, Carlos; Green, Anthony R.

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study

2015 - HAEMATOLOGICA

Rossi, D.; Bruscaggin, A.; La Cava, P.; Galimberti, S.; Ciabatti, E.; Luminari, S.; Rigacci, L.; Tucci, A.; Pulsoni, A.; Bertoldero, G.; Vallisa, D.; Rusconi, C.; Spina, M.; Arcaini, L.; Angrilli, F.; Stelitano, C.; Merli, F.; Gaidano, G.; Federico, M.; Palumbo, G. A.